A significant part of JDRF Canada’s research strategy is funding the most promising cure-based research for type 1 diabetes (T1D). T1D is an autoimmune disease where the body destroys the […]
JDRF Canada Youth Advocate Tilly Stimpson selected to represent Canada at the JDRF 2023 Children’s Congress
Every two years, more than 160 children living with type 1 diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. […]
JDRF Canada is pleased to announce the launch of JDRF Your Way
A newly re-tooled third-party fundraising program is now available across Canada: JDRF Your Way. Support. Participate. Fundraise… Your Way JDRF’s foundations lie in grassroots efforts and fundraising, and our accomplishments as […]
2022 Wrap Up
As we got through the height of the pandemic in 2021 and moved into 2022, we believed that it would be a year of hope. And thanks to the support […]
Holiday Season Carb Counting
It’s the holiday season, and for most people that means indulging in seasonal treats and meals. It’s no different for people living with type 1 diabetes (T1D). One of the […]
The BETTER project is now available across Canada
In November, to celebrate World Diabetes Day, the BETTER (BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes) project announced that it is now the first registry of people […]
Kids For A Cure 2022
JDRF’s Kids For a Cure advocacy event was held from November 13- 15 in Ottawa and what an impact our youth delegates made – engaging with more than 55 Members […]
The Turner family wants to help families like theirs affected by T1D
A diagnosis of type 1 diabetes (T1D) changes the trajectory of an entire family. This was no different for the Turner Family when Alex was diagnosed at 14-years-old. The Turners […]
JDRF Centre of Excellence at UBC celebrates 1 year of progress in T1D cure research
December 2021 marked the launch of the JDRF Centre of Excellence at the University of British Columbia (UBC). One year later, a team of over 40 researchers convened in person […]
Teplizumab approved for use in people at risk of type 1 diabetes by the US Food and Drug Administration
This is the first therapeutic on the market that may help delay the onset of clinicaltype 1 diabetes November 17, 2022 Today, the U.S. Food and Drug Administration (FDA) weighed […]
The Sun Life Ride to Defeat Diabetes was back in-person and an enormous success!
One of Canada’s longest running and top fundraising events returned to in-person Rides in Montréal and Toronto, on October 6 and 13, 2022 respectively, along with virtual rides across the country. […]
Important update on teplizumab – a therapeutic that may help delay the onset of type 1 diabetes
A key tenet of JDRF’s research funding strategy is that there are multiple pathways to cures for type 1 diabetes (T1D), one of which includes screening for risk and use […]